NL-OMON37886已完成不适用
ANCA associated vasculitis is a relapsing disease; the role of regulatory B cells - Bregs in AAV
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Over 18 years of age.
- •Study population:
- •Diagnosis Granulomatosis with polyangiitis (GPA; Wegener), or Microscopic polyangiitis according to the 1994 Chapel Hill Consensus conference
- •Positive at any time point for PR3- or MPO-ANCA.
- •Since patients can change from inactive to active patients over time, patients can be included at any time point in their disease course.;Control population:
- •Either any person who reports him or her selves as being healthy, does not use any immune modulating medication and wants to donate blood.
- •Or disease controls being diagnosed with Systemic Lupus Erythematosus, Rheumatoid Arthritis, Sjogren Syndrome or Giant Cell Arteriitis, as judged by the principle investigator.
排除标准
- •Unable to consent
- •Unable to donate blood
研究者
相似试验
Unknown
不适用
Cardiovascular disease in ANCA-associated vasculitisANCA-associated vasculitisNL-OMON24348orthwest Academy210
进行中（未招募）
不适用
SE OF ABATACEPT IN ANCA-ASSOCIATED VASCULITIS - ABAVASEUCTR2008-004138-26-ITAZIENDA OSPEDALIERA DI PARMA112
Unknown
3 期
WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated VasculitidesSystemic Wegener's GranulomatosisNCT00349674Hospices Civils de Lyon126
招募中
不适用
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T CellsANCA Associated VasculitisLupus NephritisNCT06277427Lingli Dong24
进行中（未招募）
不适用
Abatacept in ANCA associated vasculitis: ABAVAS - ABAVASAnti-neutrophil cytoplasmic antibody (ANCA) associated vasculitisMedDRA version: 8.1Level: LLTClassification code 10050894Term: Anti-neutrophil cytoplasmic antibody positive vasculitisEUCTR2006-001859-35-DEImperial College London112